BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,152,961 | +82549.5% | 30,550 | -0.2% | 0.03% | -15.0% |
| Q2 2023 | $1,395 | -7.4% | 30,618 | -17.6% | 0.04% | -16.7% |
| Q1 2023 | $1,507 | -34.9% | 37,144 | -18.2% | 0.05% | -38.5% |
| Q4 2022 | $2,314 | -99.9% | 45,399 | +21.6% | 0.08% | +4.0% |
| Q3 2022 | $2,011,000 | -18.2% | 37,344 | -2.5% | 0.08% | -14.8% |
| Q2 2022 | $2,459,000 | -19.7% | 38,284 | -3.1% | 0.09% | -6.4% |
| Q1 2022 | $3,063,000 | -6.6% | 39,502 | +3.4% | 0.09% | -4.1% |
| Q4 2021 | $3,280,000 | +0.2% | 38,218 | -6.1% | 0.10% | -10.1% |
| Q3 2021 | $3,274,000 | +73.5% | 40,705 | +73.6% | 0.11% | +73.0% |
| Q2 2021 | $1,887,000 | -6.5% | 23,447 | -2.0% | 0.06% | -10.0% |
| Q1 2021 | $2,019,000 | +31.1% | 23,928 | +24.6% | 0.07% | +18.6% |
| Q4 2020 | $1,540,000 | +4.0% | 19,199 | +4.3% | 0.06% | -7.8% |
| Q3 2020 | $1,481,000 | -6.3% | 18,409 | +0.3% | 0.06% | -15.8% |
| Q2 2020 | $1,580,000 | +44.7% | 18,357 | +36.4% | 0.08% | +16.9% |
| Q1 2020 | $1,092,000 | +14.5% | 13,457 | +18.1% | 0.06% | +44.4% |
| Q4 2019 | $954,000 | -13.5% | 11,399 | -9.6% | 0.04% | -21.1% |
| Q3 2019 | $1,103,000 | -12.2% | 12,603 | -17.9% | 0.06% | -17.4% |
| Q2 2019 | $1,256,000 | +0.1% | 15,343 | -0.6% | 0.07% | -4.2% |
| Q1 2019 | $1,255,000 | +33.2% | 15,431 | +7.8% | 0.07% | +18.0% |
| Q4 2018 | $942,000 | -30.7% | 14,317 | -18.8% | 0.06% | -20.8% |
| Q3 2018 | $1,360,000 | +2.8% | 17,640 | -1.6% | 0.08% | -4.9% |
| Q2 2018 | $1,323,000 | +20.7% | 17,919 | +6.3% | 0.08% | +6.6% |
| Q1 2018 | $1,096,000 | +1.4% | 16,854 | +0.8% | 0.08% | +4.1% |
| Q4 2017 | $1,081,000 | +1.9% | 16,726 | -1.2% | 0.07% | -3.9% |
| Q3 2017 | $1,061,000 | +1.9% | 16,922 | -1.6% | 0.08% | -2.6% |
| Q2 2017 | $1,041,000 | -60.9% | 17,189 | -66.5% | 0.08% | -61.4% |
| Q1 2017 | $2,660,000 | +15.5% | 51,297 | -1.3% | 0.20% | +9.8% |
| Q4 2016 | $2,303,000 | -9.7% | 51,954 | -3.0% | 0.18% | -16.0% |
| Q3 2016 | $2,549,000 | +4.9% | 53,547 | -0.3% | 0.22% | +2.3% |
| Q2 2016 | $2,429,000 | +6.1% | 53,704 | -3.6% | 0.21% | +0.5% |
| Q1 2016 | $2,289,000 | +275.2% | 55,711 | +248.9% | 0.21% | +280.4% |
| Q4 2015 | $610,000 | +12.1% | 15,966 | -3.6% | 0.06% | -8.2% |
| Q3 2015 | $544,000 | -55.7% | 16,570 | -5.7% | 0.06% | -53.1% |
| Q2 2015 | $1,229,000 | +11.1% | 17,575 | +8.9% | 0.13% | +10.2% |
| Q1 2015 | $1,106,000 | -4.5% | 16,143 | +2.2% | 0.12% | -4.8% |
| Q4 2014 | $1,158,000 | +5.0% | 15,798 | +2.8% | 0.12% | -1.6% |
| Q3 2014 | $1,103,000 | -0.4% | 15,369 | +0.3% | 0.13% | -0.8% |
| Q2 2014 | $1,107,000 | +6.9% | 15,318 | +8.8% | 0.13% | -0.8% |
| Q1 2014 | $1,036,000 | +4.9% | 14,075 | -0.9% | 0.13% | -1.5% |
| Q4 2013 | $988,000 | +3.5% | 14,204 | -2.2% | 0.13% | -11.6% |
| Q3 2013 | $955,000 | +1.7% | 14,526 | +7.2% | 0.15% | -4.5% |
| Q2 2013 | $939,000 | – | 13,555 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |